Andersen R, Wulff Westergaard MC, Westerlin Kjeldsen J, Mueller A, Wulff Pedersen N, Reker Hadrup S, Met O, Seliger B, Kromann-Andersen B, Hasselager T, Donia M, Svane IM. T cell responses in the microenvironment of primary renal cell carcinoma - Implications for adoptive cell therapy. Cancer Immunol Res. 2018 Jan 4. pii: canimm.0467.2017. doi: 10.1158/2326-6066.CIR-17-0467. [Epub ahead of print]


Glasner A, Levi A, Enk J, Isaacson B, Viukov S, Orlanski S, Scope A, Neuman T, Enk CD, Hanna JH, Sexl V, Jonjic S, Seliger B, Zitvogel L, Mandelboim O. NKp46 Receptor-Mediated Interferon-γ Production by Natural Killer Cells Increases Fibronectin 1 to Alter Tumor Architecture and Control Metastasis.
Immunity. 2018 Jan 4. pii: S1074-7613(17)30536-8. doi: 10.1016/j.immuni.2017.12.007. [Epub ahead of print]


in press:

Subbarayan K, Leisz S, Wickenhauser C, Bethmann D, Massa C, Steven A, Seliger B. Biglycan-mediated upregulation of MHC class I expression in HER-2/neu-transformed cells. OncoImmunology 2017. doi: 10.1080/2162402X.2017.137323


Lennicke C, Rahn J, Wickenhauser C, Lichtenfels R, Müller AS, Wessjohann LA, Kipp AP, Seliger B. Loss of epithelium-specific GPx2 results in aberrant cell fate decisions during intestinal differentiation. Oncotarget 2017. doi: 10.18632/oncotarget.22640